About this trial
It is aimed to investigate the responses of Fatty Acid Binding Protein 4 (FABP4), which has been discovered as a novel biomarker of obesity and metabolic diseases, to regular exercise training.
The aim of this study is to investigate the effects of high-intensity interval training (HIIT) on cardiometabolic risk factors, body composition, and plasma FABP4 levels in sedentary obese adults.
Eligibility criteria
Qualifiers
Aged between 20 and 35 years,
BMI between 30 and 35 kg/m²,
Waist circumference of 90-100 cm for women, 105-110 cm for men,
Sedentary lifestyle (<600 MET-min/week),
Disqualifiers
BMI > 35,
Pregnancy,
Cardiovascular Diseases: Individuals with serious cardiovascular issues, such as uncontrolled hypertension, heart failure, coronary artery disease, or a heart attack within the last 6 months, which could pose a risk during exercise.
Respiratory Diseases: Individuals with chronic respiratory conditions, such as uncontrolled or severe asthma or COPD, who cannot tolerate exercise due to their condition.
Trial design
Treatments tested in this trial
- Exercise